Login / Signup

On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long COVID.

Andriy A GorbenkoAdam A Cohen
Published in: British journal of clinical pharmacology (2024)
Keyphrases
  • open label
  • coronavirus disease
  • sars cov
  • clinical trial
  • randomized controlled trial
  • squamous cell carcinoma
  • study protocol